What is the recommended dose of Nitroglycerin (NTG) infusion for managing Hypertension (HTN)?

Nitroglycerin Infusion Dosing for Hypertension Management

For hypertensive emergencies, nitroglycerin (NTG) infusion should be initiated at 5 mcg/min and increased in 5 mcg/min increments every 3-5 minutes to a maximum of 20 mcg/min when using non-absorbing tubing. 1

Initial Dosing and Titration Protocol

Starting Dose and Titration

• Begin with 5 mcg/min through non-absorbing tubing 1, 2
• Titrate upward in 5 mcg/min increments every 3-5 minutes 1
• If no response at 20 mcg/min, can increase by 10 mcg/min and later 20 mcg/min increments 1
• Once partial blood pressure response is observed, reduce increment size and increase interval between dose changes 1
• Maximum recommended dose: 20 mcg/min for hypertensive emergencies 1
• Common ceiling dose in clinical practice: 200 mcg/min 1

Blood Pressure Targets

• For patients without compelling conditions: reduce SBP by no more than 25% within first hour 1
• Then, if stable, reduce to 160/100 mmHg within next 2-6 hours 1
• Finally, cautiously reduce to normal over the following 24-48 hours 1
• For compelling conditions (aortic dissection, severe preeclampsia/eclampsia, pheochromocytoma crisis): reduce SBP to <140 mmHg during first hour and <120 mmHg in aortic dissection 1

Important Considerations and Precautions

Contraindications and Cautions

• Avoid in patients with:
  • Initial SBP <90 mmHg or ≥30 mmHg below baseline 1
  • Marked bradycardia or tachycardia 1
  • Recent use of phosphodiesterase inhibitors (sildenafil within 24h, tadalafil within 48h) 1
  • Volume depletion 1

Monitoring Requirements

• Continuous blood pressure monitoring 1
• Systolic blood pressure should not be titrated below 110 mmHg in previously normotensive patients 1
• Do not reduce mean arterial pressure by more than 25% if hypertension was present 1

Tolerance Management

• Tolerance typically develops after 24 hours of continuous therapy 1
• Patients requiring NTG beyond 24 hours may need periodic dose increases to maintain efficacy 1
• Consider non-tolerance-producing regimens (lower doses and intermittent dosing) for longer treatment 1

Tubing Considerations

• Use non-absorbing tubing (critical for accurate dosing) 2
• When using non-absorbing tubing, doses are significantly lower than with PVC tubing 2
• If concentration is adjusted, flush or replace infusion set before using new concentration 2

Special Situations

Transitioning from IV to Oral/Topical

• When patient is stable for 12-24 hours without ischemic symptoms, attempt to reduce IV dose 1
• Switch to oral or topical nitrates using non-tolerance-producing regimen 1
• Convert to alternative route within 24 hours when possible 1

Discontinuation

• Avoid abrupt cessation as it may exacerbate symptoms 1
• Use graded reduction in dose when discontinuing 1

NTG infusion is specifically indicated for hypertensive emergencies with acute coronary syndrome and/or acute pulmonary edema, rather than as a first-line agent for all hypertensive emergencies 1.